• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Tradipitant
    |
    Weekly News Recap #Phispers Tradipitant
    BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo’s Wegovy

    BioMarin inks US$ 4.8 billion rare disease deal with Amicus; FDA approves pill version of Novo’s Wegovy

    PharmaCompass wishes its readers a very Happy New Year and brings news from the last two weeks in this double-dose edition of...

    Impressions : 1621

    Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

    Sanofi gets two bids valuing its consumer unit at US$ 17 bn; Pfizer pulls SCD drug from market

    In news this week, Sanofi is considering the sale of its consumer health unit and has received binding bids valuing the divisi...

    Impressions : 1522

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.